acetyl l carnitine and antidepressant Acetyl-l-Carnitine The neuropsychopharmacology of acetyl-L-carnitine (LAC):

In either embodiment, when only a portion of the variable or constant region is replaced, the resulting chimeric antibody can define the same antigen and/or have the same effector function yet be altered or improved so that the chimeric antibody may demonstrate a greater antigen specificity, greater affinity binding constant, increased effector function, or increased secretion and production by the transfected antibody producing cell line, etc

Importantly, color alone cannot verify the identity, potency, or sterility of a medication

These primary data suggest that carriers of the Thr92Ala polymorphism may experience inadequate intracerebral T3 availability despite standard replacement therapy, contributing to persistent symptoms

Time-resolved MS of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules

Zhao GR, Xiang ZJ, Ye TX, Yuan YJ, Guo ZX (2006) Antioxidant activities of Salvia miltiorrhiza and Panax notoginseng

Cerebral artery pulsatility is associated with cognitive impairment and predicts dementia in individuals with subjective memory decline or mild cognitive impairment